Initial clinical experiences with an interleukin-2 fusion toxin (DAB486-IL-2)

Targeted Diagn Ther. 1992:7:395-401.
No abstract available

Publication types

  • Clinical Trial
  • Review

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Diphtheria Toxin / adverse effects
  • Diphtheria Toxin / therapeutic use*
  • Female
  • Humans
  • Immunotoxins / adverse effects
  • Immunotoxins / therapeutic use*
  • Interleukin-2 / adverse effects
  • Interleukin-2 / physiology
  • Interleukin-2 / therapeutic use*
  • Lymphoma / therapy*
  • Male
  • Middle Aged
  • Receptors, Interleukin-2 / physiology
  • Recombinant Fusion Proteins / adverse effects
  • Recombinant Fusion Proteins / therapeutic use*

Substances

  • DAB(486)-interleukin 2
  • Diphtheria Toxin
  • Immunotoxins
  • Interleukin-2
  • Receptors, Interleukin-2
  • Recombinant Fusion Proteins